(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318666 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB9 mRNA CTD PMID:22079256 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SERPINB9 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SERPINB9 mRNA CTD PMID:12075121 17beta-estradiol multiple interactions ISO RGD:1318666 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SERPINB9 mRNA more ... CTD PMID:14617632 more ... 17beta-estradiol increases expression ISO RGD:1318666 6480464 Estradiol results in increased expression of SERPINB9 mRNA, Estradiol results in increased expression of SERPINB9 protein CTD PMID:10681578 , PMID:17237823 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1556995 6480464 Tetrachlorodibenzodioxin results in decreased expression of SERPINB9 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SERPINB9 mRNA CTD PMID:19692669 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SERPINB9 mRNA CTD PMID:22298810 , PMID:34747641 2,4,6-tribromophenol increases expression ISO RGD:1318666 6480464 2 more ... CTD PMID:31675489 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:19692669 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of SERPINB9 mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SERPINB9 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1556995 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SERPINB9 mRNA CTD PMID:30951980 4-hydroxynon-2-enal increases expression ISO RGD:1556995 6480464 4-hydroxy-2-nonenal results in increased expression of SERPINB9 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1556995 6480464 Fenretinide results in increased expression of SERPINB9 mRNA CTD PMID:28973697 9-cis-retinoic acid decreases expression ISO RGD:1318666 6480464 Alitretinoin results in decreased expression of SERPINB9 mRNA CTD PMID:15982314 acetamide increases expression EXP 6480464 acetamide results in increased expression of SERPINB9 mRNA CTD PMID:31881176 afimoxifene increases expression ISO RGD:1318666 6480464 afimoxifene results in increased expression of SERPINB9 mRNA CTD PMID:14617632 , PMID:17237823 afimoxifene multiple interactions ISO RGD:1318666 6480464 ESR1 protein promotes the reaction [afimoxifene results in increased expression of SERPINB9 mRNA] CTD PMID:17237823 aflatoxin B1 decreases expression ISO RGD:1556995 6480464 Aflatoxin B1 results in decreased expression of SERPINB9 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1318666 6480464 Aflatoxin B1 results in increased methylation of SERPINB9 intron CTD PMID:30157460 all-trans-4-oxoretinoic acid decreases expression ISO RGD:1318666 6480464 4-oxoretinoic acid results in decreased expression of SERPINB9 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1318666 6480464 Tretinoin metabolite results in decreased expression of SERPINB9 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:1318666 6480464 Tretinoin results in increased expression of SERPINB9 mRNA CTD PMID:21934132 more ... antirheumatic drug decreases expression ISO RGD:1318666 6480464 Antirheumatic Agents results in decreased expression of SERPINB9 mRNA CTD PMID:24449571 belinostat increases expression ISO RGD:1318666 6480464 belinostat results in increased expression of SERPINB9 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1556995 6480464 Benzo(a)pyrene results in decreased expression of SERPINB9 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:1556995 6480464 Benzo(a)pyrene results in decreased methylation of SERPINB9 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1318666 6480464 Benzo(a)pyrene affects the methylation of SERPINB9 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1318666 6480464 Benzo(a)pyrene results in increased methylation of SERPINB9 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1318666 6480464 Benzo(a)pyrene results in increased expression of SERPINB9 mRNA, Benzo(a)pyrene results in increased expression of SERPINB9 protein CTD PMID:20106945 more ... bis(2-ethylhexyl) phthalate increases expression ISO RGD:1318666 6480464 Diethylhexyl Phthalate results in increased expression of SERPINB9 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SERPINB9 mRNA CTD PMID:12075121 bisphenol A increases expression ISO RGD:1318666 6480464 bisphenol A results in increased expression of SERPINB9 mRNA CTD PMID:32028606 bisphenol A increases expression ISO RGD:1556995 6480464 bisphenol A results in increased expression of SERPINB9 mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SERPINB9 mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:1556995 6480464 bisphenol F results in increased expression of SERPINB9 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1318666 6480464 bisphenol F results in increased expression of SERPINB9 protein CTD PMID:34186270 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of SERPINB9 mRNA CTD PMID:24136188 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SERPINB9 mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:1318666 6480464 Calcitriol results in increased expression of SERPINB9 mRNA CTD PMID:16002434 carbon nanotube decreases expression ISO RGD:1556995 6480464 Nanotubes more ... CTD PMID:25620056 chlordecone increases expression ISO RGD:1556995 6480464 Chlordecone results in increased expression of SERPINB9 mRNA CTD PMID:33711761 chromium(6+) decreases expression ISO RGD:1318666 6480464 chromium hexavalent ion results in decreased expression of SERPINB9 mRNA CTD PMID:30690063 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SERPINB9 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1318666 6480464 cobaltous chloride results in decreased expression of SERPINB9 mRNA CTD PMID:19320972 copper(II) sulfate increases expression ISO RGD:1318666 6480464 Copper Sulfate results in increased expression of SERPINB9 mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO RGD:1318666 6480464 Cycloheximide promotes the reaction [moxestrol results in increased expression of SERPINB9 mRNA] CTD PMID:10681578 cyclosporin A decreases expression ISO RGD:1556995 6480464 Cyclosporine results in decreased expression of SERPINB9 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1318666 6480464 Cyclosporine results in decreased expression of SERPINB9 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A increases expression ISO RGD:1556995 6480464 Cyclosporine results in increased expression of SERPINB9 mRNA CTD PMID:23958496 cytarabine decreases expression ISO RGD:1318666 6480464 Cytarabine results in decreased expression of SERPINB9 mRNA CTD PMID:21198554 dicrotophos increases expression ISO RGD:1318666 6480464 dicrotophos results in increased expression of SERPINB9 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression ISO RGD:1318666 6480464 Endosulfan results in increased expression of SERPINB9 mRNA CTD PMID:26615145 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SERPINB9 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1318666 6480464 entinostat results in increased expression of SERPINB9 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 ethanol decreases expression ISO RGD:1318666 6480464 Ethanol results in decreased expression of SERPINB9 mRNA CTD PMID:28986285 ethanol affects expression ISO RGD:1556995 6480464 Ethanol affects the expression of SERPINB9 mRNA CTD PMID:30319688 fipronil increases expression EXP 6480464 fipronil results in increased expression of SERPINB9 mRNA CTD PMID:23962444 fulvestrant multiple interactions ISO RGD:1318666 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of SERPINB9 mRNA], fulvestrant inhibits the reaction [moxestrol results in increased expression of SERPINB9 mRNA] CTD PMID:10681578 , PMID:17237823 genistein increases expression EXP 6480464 Genistein results in increased expression of SERPINB9 mRNA CTD PMID:12075121 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SERPINB9 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SERPINB9 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of SERPINB9 mRNA CTD PMID:24136188 hydroquinone increases expression ISO RGD:1318666 6480464 hydroquinone results in increased expression of SERPINB9 mRNA CTD PMID:31256213 hypochlorous acid increases expression ISO RGD:1556995 6480464 Hypochlorous Acid results in increased expression of SERPINB9 mRNA CTD PMID:19376150 isotretinoin decreases expression ISO RGD:1318666 6480464 Isotretinoin results in decreased expression of SERPINB9 mRNA CTD PMID:15982314 ivermectin decreases expression ISO RGD:1318666 6480464 Ivermectin results in decreased expression of SERPINB9 protein CTD PMID:32959892 lipopolysaccharide increases expression ISO RGD:1318666 6480464 Lipopolysaccharides results in increased expression of SERPINB9 mRNA, Lipopolysaccharides results in increased expression of SERPINB9 protein CTD PMID:12177049 , PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1318666 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINB9 mRNA] CTD PMID:35811015 mercury dibromide increases expression ISO RGD:1318666 6480464 mercuric bromide results in increased expression of SERPINB9 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SERPINB9 mRNA CTD PMID:19564919 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SERPINB9 mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of SERPINB9 mRNA CTD PMID:30467583 methotrexate decreases expression ISO RGD:1318666 6480464 Methotrexate results in decreased expression of SERPINB9 mRNA CTD PMID:24449571 methyl methanesulfonate decreases expression ISO RGD:1318666 6480464 Methyl Methanesulfonate results in decreased expression of SERPINB9 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1318666 6480464 methylmercuric chloride results in decreased expression of SERPINB9 mRNA CTD PMID:23179753 methylmercury chloride increases expression ISO RGD:1318666 6480464 methylmercuric chloride results in increased expression of SERPINB9 mRNA CTD PMID:28001369 Moxestrol multiple interactions ISO RGD:1318666 6480464 Cycloheximide promotes the reaction [moxestrol results in increased expression of SERPINB9 mRNA] more ... CTD PMID:10681578 more ... Moxestrol increases expression ISO RGD:1318666 6480464 moxestrol results in increased expression of SERPINB9 mRNA, moxestrol results in increased expression of SERPINB9 protein CTD PMID:10681578 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SERPINB9 mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SERPINB9 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1318666 6480464 Nickel results in increased expression of SERPINB9 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:1318666 6480464 nickel sulfate results in increased expression of SERPINB9 mRNA CTD PMID:22714537 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of SERPINB9 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB9 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1556995 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SERPINB9 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SERPINB9 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:1318666 6480464 p-Chloromercuribenzoic Acid results in increased expression of SERPINB9 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 p-menthan-3-ol increases expression ISO RGD:1318666 6480464 Menthol results in increased expression of SERPINB9 mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1318666 6480464 panobinostat results in increased expression of SERPINB9 mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:1318666 6480464 Acetaminophen results in increased expression of SERPINB9 mRNA CTD PMID:21420995 more ... paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SERPINB9 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1556995 6480464 perfluorooctane sulfonic acid results in decreased expression of SERPINB9 protein CTD PMID:26178269 phenylmercury acetate increases expression ISO RGD:1318666 6480464 Phenylmercuric Acetate results in increased expression of SERPINB9 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:1318666 6480464 Tetradecanoylphorbol Acetate results in increased expression of SERPINB9 mRNA, Tetradecanoylphorbol Acetate results in increased expression of SERPINB9 protein CTD PMID:12177049 pirinixic acid decreases expression ISO RGD:1556995 6480464 pirinixic acid results in decreased expression of SERPINB9 mRNA CTD PMID:20813756 potassium chromate multiple interactions ISO RGD:1318666 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB9 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1318666 6480464 potassium chromate(VI) results in decreased expression of SERPINB9 mRNA CTD PMID:22079256 , PMID:22714537 progesterone multiple interactions ISO RGD:1318666 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SERPINB9 mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:1318666 6480464 Quercetin results in increased expression of SERPINB9 mRNA CTD PMID:15309432 raloxifene affects binding ISO RGD:1318666 6480464 [Raloxifene Hydrochloride binds to ESR1 protein] which binds to SERPINB9 protein CTD PMID:14617632 raloxifene multiple interactions ISO RGD:1318666 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in increased expression of SERPINB9 mRNA] CTD PMID:17237823 resorcinol increases expression ISO RGD:1318666 6480464 resorcinol results in increased expression of SERPINB9 mRNA CTD PMID:22623647 rifampicin increases expression ISO RGD:1318666 6480464 Rifampin results in increased expression of SERPINB9 mRNA CTD PMID:24552687 rifampicin multiple interactions ISO RGD:1318666 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB9 mRNA CTD PMID:21127053 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SERPINB9 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1318666 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of SERPINB9 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1318666 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SERPINB9 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SERPINB9 mRNA CTD PMID:19564919 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SERPINB9 mRNA CTD PMID:32721576 silicon dioxide increases expression ISO RGD:1318666 6480464 Silicon Dioxide results in increased expression of SERPINB9 mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:1318666 6480464 Silver results in increased expression of SERPINB9 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1318666 6480464 Silver results in increased expression of SERPINB9 mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:1318666 6480464 sodium arsenite results in increased expression of SERPINB9 mRNA CTD PMID:22714537 sodium arsenite increases expression ISO RGD:1556995 6480464 sodium arsenite results in increased expression of SERPINB9 protein CTD PMID:29044176 Soman decreases expression EXP 6480464 Soman results in decreased expression of SERPINB9 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1556995 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB9 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB9 mRNA CTD PMID:21641980 , PMID:26378955 sunitinib decreases expression ISO RGD:1318666 6480464 Sunitinib results in decreased expression of SERPINB9 mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:1318666 6480464 T-2 Toxin results in increased expression of SERPINB9 protein CTD PMID:34581912 tacrolimus hydrate increases expression ISO RGD:1556995 6480464 Tacrolimus results in increased expression of SERPINB9 mRNA CTD PMID:23958496 tamoxifen multiple interactions ISO RGD:1318666 6480464 Tamoxifen analog inhibits the reaction [moxestrol results in increased expression of SERPINB9 mRNA] CTD PMID:10681578 tamoxifen affects expression ISO RGD:1556995 6480464 Tamoxifen affects the expression of SERPINB9 mRNA CTD PMID:20937368 tamoxifen increases expression ISO RGD:1318666 6480464 Tamoxifen analog results in increased expression of SERPINB9 mRNA CTD PMID:10681578 tetrachloromethane affects expression ISO RGD:1556995 6480464 Carbon Tetrachloride affects the expression of SERPINB9 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SERPINB9 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:1556995 6480464 titanium dioxide results in increased expression of SERPINB9 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB9 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SERPINB9 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SERPINB9 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1318666 6480464 trichostatin A results in increased expression of SERPINB9 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1318666 6480464 Triclosan results in increased expression of SERPINB9 mRNA CTD PMID:30510588 triptonide increases expression ISO RGD:1556995 6480464 triptonide results in increased expression of SERPINB9 mRNA CTD PMID:33045310 urethane increases expression ISO RGD:1318666 6480464 Urethane results in increased expression of SERPINB9 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1556995 6480464 Valproic Acid affects the expression of SERPINB9 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1318666 6480464 Valproic Acid results in increased expression of SERPINB9 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1318666 6480464 Valproic Acid affects the expression of SERPINB9 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1318666 6480464 Valproic Acid results in increased methylation of SERPINB9 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:1556995 6480464 Vancomycin results in decreased expression of SERPINB9 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SERPINB9 mRNA CTD PMID:19015723 vorinostat multiple interactions ISO RGD:1318666 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1318666 6480464 vorinostat results in increased expression of SERPINB9 mRNA CTD PMID:26272509 zinc atom decreases expression ISO RGD:1318666 6480464 Zinc results in decreased expression of SERPINB9 mRNA CTD PMID:18316168 zinc(0) decreases expression ISO RGD:1318666 6480464 Zinc results in decreased expression of SERPINB9 mRNA CTD PMID:18316168